Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
physiological solution-Nantes University Hospital-discal sciatica refers to a specific placebo/control intervention used in the HIATUS (Efficacy of Corticoid Infiltration Via Sacro-coccygien Hiatus in Discal Sciatica) Phase 3 clinical trial (NCT01482897). Conducted by Nantes University Hospital, this intervention consists of a 10 ml anesthetic block using 1% xylocaine (lidocaine) followed immediately by a 20 ml injection of physiological saline solution administered via the sacro-coccygeal hiatus. The solution serves as a control to determine if the therapeutic effects observed in patients with subacute discal sciatica (affecting L4L5 or L5S1 levels) are due to the active corticosteroid (prednisolone acetate), the mechanical volume effect of the injection, or the natural history of the condition. While the saline itself is pharmacologically inert, the intervention includes a local anesthetic to maintain the study's blinding and procedural standards.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on physiological solution-Nantes University Hospital-discal sciatica.